Trinity Biotech, a developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, has announced that Ronan O'Caoimh, executive chairman, has agreed to resume the role of CEO.
Subscribe to our email newsletter
Mr O’Caoimh will succeed Brendan Farrell, who has resigned with immediate effect, having served as Trinity’s president since 1994 and as CEO since November 2007.
Mr O’Caoimh said: “I am hugely excited by this challenge and, given our product offering and development pipeline, am determined to deliver on our enormous potential for enhanced shareholder value.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.